ArticleExperimental neurology2026
Infarct-associated oligoclonal T cell expansion in chronic experimental stroke across age, sex, and models.
Article in Experimental neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
Ischemic stroke induces prolonged T cell accumulation within injured brain tissue, yet it remains unclear whether these cells reflect nonspecific inflammatory persistence or organized adaptive immune responses. To define the clonal architecture of post-stroke T cells, we performed genomic DNA-based bulk T cell receptor (TCR) immunosequencing of CDR3α and CDR3β repertoires from infarcted brain and spleen during the chronic phase of experimental stroke across age and sex. TCRβ repertoires were further examined across three ischemic stroke models reproduced independently at sites in the United States and Europe. Chronic infarct tissue consistently exhibited oligoclonal T cell expansion across age, sex, stroke models, and laboratories; spleen and blood remained broadly polyclonal. Dominant clonotypes occupied a substantial fraction of the infarct repertoire, revealing a structured clonal architecture within the injured brain. Computational annotation identified recurrent sequence similarities to self-associated TCRs, including receptors linked to myelin, nuclear, and insulin-related antigens, although many expanded clonotypes lacked database matches. These annotations are presented as hypothesis-generating rather than evidence of antigen specificity. Together, these findings demonstrate that chronic ischemic brain injury is associated with a reproducible, infarct-associated clonal T cell signature whose conserved architecture is consistent with antigen-driven selection, although stochastic or cytokine-driven expansion cannot be excluded. The accompanying publicly available TCR repertoire dataset provides a clonotype-resolved reference resource for future investigations of antigen specificity and adaptive immune dynamics in chronic post-stroke neuroinflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.